Winshine Science Co (HKSE:00209) Operating Income : HK$-17.7 Mil (TTM As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Winshine Science Co Operating Income?

Winshine Science Co's Operating Income for the six months ended in Dec. 2023 was HK$3.8 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-17.7 Mil.

Warning Sign:

Winshine Science Co Ltd has never been profitable in the past 3 years. It lost money every year.

Operating Margin % is calculated as Operating Income divided by its Revenue. Winshine Science Co's Operating Income for the six months ended in Dec. 2023 was HK$3.8 Mil. Winshine Science Co's Revenue for the six months ended in Dec. 2023 was HK$320.6 Mil. Therefore, Winshine Science Co's Operating Margin % for the quarter that ended in Dec. 2023 was 1.20%.

Good Sign:

Winshine Science Co Ltd operating margin is expanding. Margin expansion is usually a good sign.

Winshine Science Co's 5-Year average Growth Rate for Operating Margin % was 17.90% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Winshine Science Co's annualized ROC % for the quarter that ended in Dec. 2023 was 8.68%. Winshine Science Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 11.71%.

Winshine Science Co Operating Income Historical Data

The historical data trend for Winshine Science Co's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winshine Science Co Operating Income Chart

Winshine Science Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Income

Get a 7-Day Free Trial

-24.82

-84.03

-69.58

-11.25

-17.72

Winshine Science Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Income	Get a 7-Day Free Trial															-42.40	16.65	-27.90	-21.57	3.84

Winshine Science Co Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-17.7 Mil.

Winshine Science Co (HKSE:00209) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Winshine Science Co's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	7.686 * ( 1 - -336.84% )	/	( (367.912	+	405.497)	/ 2 )
=	33.5755224	/	386.7045
=	8.68 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	423.907	-	235.875	-	( 38.789	-	max(0, 483.999	-	304.119	+	38.789	))
=	367.912

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	414.325	-	194.012	-	( 119.335	-	max(0, 477.091	-	291.907	+	119.335	))
=	405.497

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Winshine Science Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	14.186	/	( ( (118.701 + max(2.034, 0))	+	(121.514 + max(-88.533, 0)) )	/	2 )
=	14.186	/	( ( 120.735	+	121.514 )	/	2 )
=	14.186	/	121.1245
=	11.71 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(128.082	+	109.827	+	5.6843418860808E-14)	-	(235.875	+	0	+	0)
=	2.034

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(70.482	+	75.974	+	0)	-	(194.012	+	0	+	40.977)
=	-88.533

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Winshine Science Co's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:

Operating Margin %	=	Operating Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	3.843	/	320.576
	=	1.20 %

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

Winshine Science Co Operating Income Related Terms

Thank you for viewing the detailed overview of Winshine Science Co's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Winshine Science Co (HKSE:00209) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Winshine Science Co Ltd (HKSE:00209) » Definitions » Operating Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

287-299 Queen's Road, Room 1002, 10th Floor, 299 QRC, Central, Hong Kong, HKG

Website

http://www.winshine.com

Winshine Science Co Ltd is an investment holding company. The company's segment includes Securities investments, Toys, and Medical & health. It generates maximum revenue from the Toys segment. The toys segment derives its revenue from manufacturing for the sale of toys. The securities investments segment derives its profits or losses from dividends received from, and other gains or losses from, equity securities investments. The medical and health segment is under the development stage in which research and development expenses for medical and health technology development have been incurred. Its geographical segments are Hong Kong, China, the United States, Europe, and Korea, of which the majority of its revenue comes from the United States.

Executives

Wang Honggang	2101 Beneficial owner
U Credit (hk) Limited	2106 Person having a security interest in shares
Csc Holdings Limited	2106 Person having a security interest in shares
Hurray Talent Investment Development Limited	2101 Beneficial owner
Li Zhonghai	2201 Interest of corporation controlled by you
Liu Lian	2201 Interest of corporation controlled by you
Richsun Investment Development Limited	2101 Beneficial owner
Hong Kong Huiheng Trading And Investment Co., Limited	2101 Beneficial owner
Jiang Qinghui	2201 Interest of corporation controlled by you
Csc Holdings Limited (formerly Known As "china Strategic Holdings Limited")	2106 Person having a security interest in shares
China Strategic Holdings Limited	2106 Person having a security interest in shares
Shen Jia	2101 Beneficial owner

Winshine Science Co (HKSE:00209) Headlines

No Headlines